Why is Valiant Laborato falling/rising?

As of 10-Jun, Valiant Laboratories Ltd is experiencing a price increase, currently at Rs 113.05, reflecting a rise of 2.55 or 2.31%. The stock has shown a strong performance today, outperforming its sector by 1.79% and achieving a consecutive gain over the last four days, resulting in a total return of 6.65% during this period. Additionally, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive technical trend. Positive financial results, including a higher profit after tax and record net sales, have contributed to this upward movement. However, the company faces challenges with weak long-term fundamentals, including a negative return on equity and declining sales growth, which could temper investor enthusiasm.
In the broader market context, Valiant Laboratories has outperformed the Sensex over the past week, with a return of 4.77% compared to the benchmark's 2.05%. However, it has underperformed over the longer term, with a year-to-date return of 2.08% against the Sensex's 5.44%. The increasing participation of institutional investors, who have raised their stake in the company, may provide some support to the stock. Nonetheless, the overall weak long-term growth prospects and negative EBITDA suggest that while the stock is currently rising, it remains a risky investment in the context of its historical performance and market conditions.